NCT02759198View on ClinicalTrials.gov

A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

May 2, 2016

Primary Completion Date

May 24, 2017

Study Completion Date

September 26, 2017

Conditions
Knee Osteoarthritis
Interventions
DRUG

YH23537

Drug: YH23537 750mg Drug: YH23537 1500mg Drug: YH23537 3000mg

DRUG

Celecoxib

Drug: Celecoxib 200mg

DRUG

YH23537 placebo

Drug: YH23537 750mg placebo Drug: YH23537 1500mg placebo Drug: YH23537 3000mg placebo

Trial Locations (1)

02447

KyungHee University Medical Center, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02759198 - A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis | Biotech Hunter | Biotech Hunter